Bide Pharmatech (SH:688073) Zheng Quan Zhi Xing·2025-06-02 08:16Core Points - The company, Shanghai Bid Pharmaceutical Technology Co., Ltd., has announced a differentiated cash dividend distribution plan for the year 2024, proposing a cash dividend of 0.90 CNY per share (including tax) [2][4] - The total cash dividend to be distributed amounts to approximately 77.86 million CNY (including tax), based on a total share capital of 90,882,948 shares, after deducting 4,371,774 shares held in the company's repurchase account [2][3] - The company will not issue bonus shares or increase capital reserves, and the distribution will only involve cash dividends [2][3] Dividend Distribution Details - The cash dividend distribution will be based on the total share capital after deducting shares in the repurchase account, with each shareholder receiving 9.00 CNY for every 10 shares held [2][3] - The reference price for the ex-dividend trading will be calculated as the previous closing price minus the cash dividend of 0.86 CNY per share, with no change in the number of circulating shares [3] - The relevant dates for the dividend distribution include the record date, ex-dividend date, and cash dividend payment date, which are specified in the announcement [3] Tax Implications - For individual shareholders holding shares for more than one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.90 CNY per share [4][5] - For shares held for less than one year, the tax will be calculated upon transfer, with a 20% tax rate applied for shares held for one month or less, leading to a net distribution of 0.81 CNY per share after tax [5][6] - Qualified foreign institutional investors (QFII) will have a 10% corporate income tax withheld, resulting in a net distribution of 0.81 CNY per share [6][7] Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the company's secretariat at 021-61601560 [8]